A new drug designed to treat Alzheimer’s disease looks set to be an effective treatment for vascular dementia. A recent 12-month clinical trial of the drug Galantamine (Reminyl), which is derived from the daffodil, revealed that the drug improved cognitive function, delayed the effects of dementia, and prevented behavioral decline.
SOURCE/REFERENCE: Reported by www.health-news.co.uk on the 19th June 2001
